Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Cell Counting Kit-8 (CCK-8): Precision Cell Viability Assays
2026-07-24
Cell Counting Kit-8 (CCK-8) is a highly sensitive assay for cell viability and proliferation quantification. Utilizing water-soluble tetrazolium salt (WST-8), CCK-8 enables rapid, reproducible results with minimal workflow complexity. Its advantages over older tetrazolium-based assays make it a preferred choice for diverse biomedical and cancer research contexts.
-
Clozapine N-oxide in Chemogenetics: Precision Neuronal Modul
2026-07-24
Clozapine N-oxide (CNO) propels chemogenetic research by enabling highly selective, non-invasive neuronal activity modulation. Its unparalleled specificity for engineered DREADDs makes it a transformative neuroscience research tool, as shown in recent studies on anesthesia emergence and circuit interrogation.
-
YBX1, DNA Methylation, and SHANK3 Regulation in Schizophreni
2026-07-23
This study uncovers how DNA methylation and the transcription factor YBX1 regulate SHANK3 expression in cortical interneurons and PBMCs from schizophrenia patients. The findings offer new mechanistic insights into the neurodevelopmental origins of schizophrenia and identify potential peripheral biomarkers for early detection and therapeutic targeting.
-
Short-Scale Break-Induced Replication in Mouse Oocytes: Mech
2026-07-23
This article examines a recent study that uncovers how DNA double-strand breaks (DSBs) can trigger short-scale break-induced replication (ssBIR) and amplify DNA damage in fully grown mouse oocytes. The findings demonstrate the mechanistic role of Rad51 and DNA polymerase, and highlight the impact of chain-terminating nucleotide analogs like ddATP in modulating these genomic repair processes.
-
ALT Cancer Cells and ATR Inhibition: No Universal Hypersensi
2026-07-22
This study rigorously tests whether cancer cells using alternative lengthening of telomeres (ALT) are generally hypersensitive to ATR inhibition. Contrary to prior reports, the authors find no consistent hypersensitivity across ALT-positive lines, revealing greater complexity in therapeutic targeting of telomere maintenance mechanisms.
-
Optimizing Cell Cytotoxicity Measurement with LDH Cytotoxici
2026-07-22
The LDH Cytotoxicity Assay Kit (SKU: K2228) offers a non-radioactive, quantitative workflow for assessing cell membrane integrity through LDH release. This kit is appropriate for researchers needing reliable cell cytotoxicity measurement in apoptosis detection, cell damage quantification, and biocompatibility studies. It is not suitable for applications requiring real-time or single-cell cytotoxicity analysis.
-
AICAR in Metabolic Disease Research: Protocols and Innovatio
2026-07-21
AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) empowers energy metabolism and inflammation research with robust, reproducible AMPK activation. This guide translates the latest reference breakthroughs and practical workflows into actionable insights for metabolic disease and cellular stress studies.
-
Zosuquidar (LY335979): Elevating Translational MDR Research
2026-07-21
This thought-leadership article offers translational researchers a mechanistic deep dive and strategic roadmap for leveraging Zosuquidar (LY335979) 3HCl in overcoming multidrug resistance (MDR) in cancer. Integrating the latest resistance findings from PROTAC-based therapies, the piece contextualizes Zosuquidar's unique P-glycoprotein inhibition profile and provides practical protocol guidance for preclinical and translational workflows. The article links primary research with advanced applications, moving beyond standard product content by distilling new evidence and competitive insights.
-
Palmitic acid (Hexadecanoic Acid): Research Protocols & QC G
2026-07-20
Palmitic acid (SKU N2456) offers researchers a high-purity, well-characterized saturated long-chain fatty acid suitable for in vitro studies of lipid metabolism, protein palmitoylation, and related signaling pathways. This product is not appropriate for protocols requiring aqueous solubility or long-term solution storage, making precise preparation and immediate use essential for reproducible results.
-
Fenofibrate: Age-Independent PPARα-YAP Modulation in Liver R
2026-07-20
This thought-leadership article unpacks the mechanistic basis and translational significance of Fenofibrate’s PPARα agonist activity, with a focus on its age-independent effects on liver enlargement via the YAP signaling pathway. Drawing on the latest in vivo evidence, the discussion provides actionable insights for metabolic, aging, and cancer biology researchers, and strategically situates APExBIO’s Fenofibrate (SKU B1943) as a benchmark tool for robust, reproducible experimentation.
-
WP1066, JAK2/STAT3 Inhibitor: Precision Tools for Tumor and
2026-07-19
Explore how WP1066, a potent JAK2/STAT3 inhibitor, uniquely advances cancer and immune modulation research beyond standard workflows. Gain in-depth insights into mechanistic selectivity, advanced applications, and translational possibilities for renal cell carcinoma and AML studies.
-
Caffeic Acid Phenethyl Ester (CAPE): Advanced Bench Workflow
2026-07-18
Caffeic Acid Phenethyl Ester (CAPE) is a potent and selective NF-κB inhibitor with proven value in dissecting neuroinflammation and tumor invasion pathways. This article translates cutting-edge findings into practical workflows, highlights troubleshooting strategies, and reveals how CAPE enables targeted modulation of angiogenesis and inflammatory cascades.
-
Ibuprofen as an Anti-Proliferative Agent in Colon Cancer Res
2026-07-17
Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) is redefining its role in research by offering robust anti-proliferative activity in colon carcinoma models, extending well beyond its function as a non-steroidal anti-inflammatory drug. This guide details optimized workflows, advanced troubleshooting, and cutting-edge applications powered by APExBIO’s high-purity Ibuprofen for reproducible, mechanistic insights.
-
Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis Mea
2026-07-17
The Caspase-3 Colorimetric Assay Kit by APExBIO transforms apoptosis research by delivering rapid, sensitive, and reproducible DEVD-dependent caspase-3 activity detection. Its streamlined workflow and robust protocol flexibility empower researchers to interrogate immune dynamics, neurodegeneration, and cell death with unmatched confidence.
-
Cy5 amine (non-sulfonated): Technical Guide for Biomolecule
2026-07-16
Cy5 amine (non-sulfonated) enables efficient covalent labeling of proteins, peptides, and polymers in research workflows where water-insoluble, bright, and photostable dyes are required. It is not suitable for direct aqueous labeling or any diagnostic or clinical use. Strict solvent handling and protocol compliance are essential for high-quality conjugation results.